Theravance Biopharma (TBPH) Earnings
|
Expand Research on TBPH
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +34.3% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +8.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/26  |
Q425 | N/A | $1.00 | N/A | N/A | $49.75M | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | $1.00 | N/A | N/A | $49.75M | N/A | N/A | N/A | ||
| 3/2/26 |
Q425 | N/A | $1.00 | N/A | N/A | $49.75M | N/A | N/A | N/A | ||
| 11/10/25 | Q325 | $0.07 | -$0.13 | +$0.20 | $19.99M | $19.27M | N/A |  | | Details | |
| 8/12/25 | Q225 | $1.08 | $0.67 | +$0.41 | $26.2M | $15.92M | N/A | | | Details | |
| 5/8/25 | Q125 | -$0.27 | -$0.22 | -$0.05 | $15.4M | $15.14M | N/A | | | Details | |
| 2/26/25 | Q424 | -$0.31 | -$0.20 | -$0.11 | $18.8M | $16.6M | N/A | | | Details | |
| 11/12/24 | Q324 | -$0.26 | -$0.23 | -$0.03 | $16.87M | $15.68M | N/A | | | Details |
